Dr. Brad Rodu, senior fellow at The Heartland Institute, will testify on Wednesday, September 19 before the Indiana General Assembly’s Health Finance Commission on tobacco harm reduction.
To book Dr. Rodu on your program or schedule an interview, please contact Tammy Nash at firstname.lastname@example.org and 312/377-4000. After regular business hours, contact Jim Lakely at email@example.com and 312/731-9364.
Where: House Chambers, 200 West Washington Street, Indianapolis, Indiana
When: 10 a.m., Wednesday, September 19
What: HR 59
Subject: Tobacco Harm Reduction, debunking myths about smokeless tobacco use
Dr. Rodu, the Endowed Chair in Tobacco Harm Reduction Research at the University of Louisville’s James Graham Brown Cancer Center, will testify before the commission about:
- how smokeless tobacco use is 98 percent safer than smoking cigarettes – not nearly the same risk, as is often presumed;
- how Sweden has a high rate of smokeless tobacco use, the lowest smoking rate in Europe, and the lowest rate of lung cancer and other smoking-related diseases in Europe;
- how common smoking cessation programs and products in the United States have a very low record of success compared to other tobacco harm reduction strategies.
The Heartland Institute is a 28-year-old national nonprofit organization headquartered in Chicago, Illinois. Its mission is to discover, develop, and promote free-market solutions to social and economic problems. For more information, visit our Web site or call 312/377-4000.